Closing Bell: Hls Therapeutics Inc down on Tuesday (HLS)

In market activity today, Hls Therapeutics Inc shares closed at $3.26 after opening the day at $3.40. It traded at a low of $3.25 to a high of $3.40.

Share prices decreased -9.19 percent from the previous day's close of $3.59.

Today across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 802 on 6 total trades, while having an average volume of 1,426 over the last 5-days.

The TSX market on the whole today saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.40 (July 26,2023) and low as $3.18 (July 18,2024). Moreover, in the last 52 weeks, Hls Therapeutics Inc's shares have shrunken -46.99 percent, while they have lost -17.47% this year.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $114.21 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Based on 5.00 analysts, Hls Therapeutics Inc gets an average recommendation of "Moderate Buy" according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..